A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2020-12-04
DOI
10.1080/17474124.2021.1860019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
- (2020) Jean-François Dufour et al. GUT
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Redefining fatty liver disease classification in 2020
- (2020) Luca Valenti et al. LIVER INTERNATIONAL
- What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
- (2020) Yasser Fouad et al. LIVER INTERNATIONAL
- From NAFLD to MAFLD: when pathophysiology succeeds
- (2020) Herbert Tilg et al. Nature Reviews Gastroenterology & Hepatology
- Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
- (2020) Angeliki Katsarou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Redefining non-alcoholic fatty liver disease: what's in a name?
- (2020) The Lancet Gastroenterology & Hepatology Lancet Gastroenterology & Hepatology
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- MAFLD vs NAFLD: Let the contest begin!
- (2020) Cristiana Bianco et al. LIVER INTERNATIONAL
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- (2020) Sakura Yamamura et al. LIVER INTERNATIONAL
- Redefining fatty liver disease: an international patient perspective
- (2020) Gamal Shiha et al. Lancet Gastroenterology & Hepatology
- The NAFLD‐MAFLD debate: Eminence vs evidence
- (2020) Yasser Fouad et al. LIVER INTERNATIONAL
- The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease
- (2020) Nahum Mendez-Sanchez et al. Lancet Gastroenterology & Hepatology
- Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa
- (2020) Gamal Shiha et al. Lancet Gastroenterology & Hepatology
- Noninvasive diagnosis of liver fibrosis in NAFLD: Tips tricks
- (2019) Floraine Zuberbuhler et al. Clinics and Research in Hepatology and Gastroenterology
- New dual peroxisome proliferator activated receptor agonist—Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence
- (2019) Upendra Kaul et al. Cardiovascular Diabetology
- Are Nonalcoholic Fatty Liver Disease and Alcoholic Fatty Liver Disease More Than Just Semantics?
- (2019) Mohammed Eslam et al. GASTROENTEROLOGY
- Non-alcoholic fatty liver disease: A growing public health problem in Turkey
- (2019) Eda Kaya et al. Turkish Journal of Gastroenterology
- Phase 3 drug pipelines in the treatment of NASH
- (2019) Yoshio Sumida et al. HEPATOLOGY RESEARCH
- Alcohol Use is Associated with Hepatic Steatosis Among Persons with Presumed Non-alcoholic Fatty Liver Disease
- (2019) Michelle T. Long et al. Clinical Gastroenterology and Hepatology
- Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non‐alcoholic Fatty Liver Disease
- (2019) Fasiha Kanwal et al. HEPATOLOGY
- Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives
- (2019) Grazia Pennisi et al. International Journal of Environmental Research and Public Health
- Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
- (2019) Mohammad Shadab Siddiqui et al. JOURNAL OF HEPATOLOGY
- Non-heavy drinking and worsening of non-invasive fibrosis markers in nonalcoholic fatty liver disease: A cohort study
- (2018) Yoosoo Chang et al. HEPATOLOGY
- Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future
- (2018) Ana Ruth Araújo et al. LIVER INTERNATIONAL
- Effect of alcohol consumption on survival in non-alcoholic fatty liver disease: a national prospective cohort study
- (2018) Kaveh Hajifathalian et al. HEPATOLOGY
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Max G Griswold et al. LANCET
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Renaming schizophrenia: 5 × 5
- (2018) Sinan Guloksuz et al. Epidemiology and Psychiatric Sciences
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
- (2017) Brandon J Perumpail et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children
- (2016) David E. Kleiner et al. Clinics in Liver Disease
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- NAFLD and liver transplantation: Current burden and expected challenges
- (2016) Raluca Pais et al. JOURNAL OF HEPATOLOGY
- Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2016) Gregory Thomas Brown et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Alcohol consumption and risk of fatty liver disease: a meta-analysis
- (2016) Guoli Cao et al. PeerJ
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Time to Abandon NASH?
- (2015) Jean-François Dufour HEPATOLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Current efforts and trends in the treatment of NASH
- (2015) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Characteristics and diagnosis of NAFLD/NASH
- (2013) Etsuko Hashimoto et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Multivariate modelling of endophenotypes associated with the metabolic syndrome in Chinese twins
- (2010) Z. Pang et al. DIABETOLOGIA
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started